Frontier Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-5,612
| Closed | -$266K | – | 277 |
|
2020
Q1 | $266K | Sell |
5,612
-4,525
| -45% | -$214K | 0.02% | 203 |
|
2019
Q4 | $595K | Buy |
10,137
+257
| +3% | +$15.1K | 0.03% | 155 |
|
2019
Q3 | $527K | Buy |
9,880
+3,557
| +56% | +$190K | 0.03% | 144 |
|
2019
Q2 | $316K | Buy |
6,323
+1,363
| +27% | +$68.1K | 0.02% | 190 |
|
2019
Q1 | $259K | Sell |
4,960
-400
| -7% | -$20.9K | 0.02% | 210 |
|
2018
Q4 | $256K | Buy |
5,360
+480
| +10% | +$22.9K | 0.02% | 192 |
|
2018
Q3 | $245K | Sell |
4,880
-80
| -2% | -$4.02K | 0.02% | 206 |
|
2018
Q2 | $250K | Buy |
4,960
+80
| +2% | +$4.03K | 0.02% | 195 |
|
2018
Q1 | $238K | Sell |
4,880
-160
| -3% | -$7.81K | 0.02% | 191 |
|
2017
Q4 | $223K | Sell |
5,040
-240
| -5% | -$10.6K | 0.02% | 207 |
|
2017
Q3 | $268K | Hold |
5,280
| – | – | 0.02% | 188 |
|
2017
Q2 | $285K | Sell |
5,280
-222
| -4% | -$12K | 0.03% | 187 |
|
2017
Q1 | $284K | Buy |
5,502
+222
| +4% | +$11.5K | 0.03% | 160 |
|
2016
Q4 | $254K | Sell |
5,280
-112
| -2% | -$5.39K | 0.02% | 165 |
|
2016
Q3 | $2.91M | Sell |
5,392
-533
| -9% | -$287K | 0.03% | 154 |
|
2016
Q2 | $321K | Sell |
5,925
-361
| -6% | -$19.6K | 0.04% | 147 |
|
2016
Q1 | $319K | Buy |
6,286
+1,056
| +20% | +$53.6K | 0.04% | 137 |
|
2015
Q4 | $264K | Buy |
5,230
+496
| +10% | +$25K | 0.04% | 134 |
|
2015
Q3 | $228K | Buy |
+4,734
| New | +$228K | 0.04% | 139 |
|